Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Mapleton Agri Biotec
Mapleton, Queensland, Australia
- Ownership
- Private
- Development stage
- Other
01
Overview
Mapleton Agri Biotec's core products, such as TwinN and PastureN, are microbial inoculums that have demonstrated consistent commercial results, including increased yields, enhanced nitrogen use efficiency, phosphorus uptake, and improved tolerance to environmental stress in diverse cropping systems, validated through field trials in multiple countries.
- Therapeutic areas
- Women's HealthOther
- Modalities
- Microbial inoculumBiofertilizer
- Industry
- Agriculture & AgTech
Beyond the preview
Go deeper on Mapleton Agri Biotec.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Mapleton Agri Biotec.